Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132849) titled 'Research on the Health Management Needs and Navigation Matrix Model for Patients with Kidney Cancer Undergoing Immune- Targeted Therapy from the Perspective of Journey Maps' on Sept. 18.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital
Condition:
Kidney cancer
Intervention:
Intervention group:navigation matrix model
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-09
Target Sample Size: Intervention group:29;Control group:29;
Countries of Recruitment:
China
To know more, ...